Brazil’s Eurofarma Teams With Japan’s Eisai to Bring the Insomnia Drug Dayvigo to Market
Eurofarma has partnered with Japan's Eisai to sell the insomnia drug lemborexant (Dayvigo) in Brazil, targeting a market worth about US$240 million a year. The post Brazil’s Eurofarma Teams With Japan’s Eisai to Bring the Insomnia Drug Dayvigo to Market appeared first on The Rio Times .
Read the full story at The Rio Times →